Evidence map›Paper›PMID 37796344›Full record

ArticleMikrochimica acta2023

Fabricating a designer capsule phase microextraction platform based on sol-gel Carbowax 20M-zwitterionic ionic liquid composite sorbent for the extraction of lipid-lowering drugs from human urine samples.

Argyroula Kechagia, Natalia Manousi, Abuzar Kabir, Kenneth G Furton, Constantinos K Zacharis

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Argyroula KechagiaLaboratory of Pharmaceutical Analysis, Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Natalia ManousiLaboratory of Pharmaceutical Analysis, Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Abuzar KabirDepartment of Chemistry and Biochemistry, International Forensic Research Institute, Florida International University, Miami, FL, 33131, USA. akabir@fiu.edu.
Kenneth G FurtonDepartment of Chemistry and Biochemistry, International Forensic Research Institute, Florida International University, Miami, FL, 33131, USA.
Constantinos K ZacharisLaboratory of Pharmaceutical Analysis, Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. czacharis@pharm.auth.gr.ORCID http://orcid.org/0000-0001-9362-8523
Aristotle University of Thessaloniki · GRFlorida International University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A sol-gel Carbowax 20 M/3-[(3-Cholamidopropyl) dimethyl ammonio]-1-propanesulfonate composite sorbent-based capsule phase microextraction device has been fabricated and characterized for the determination of four statins (pravastatin, rosuvastatin, pitavastatin, and atorvastatin) in human urine. The presence of ionizable carboxyl functional groups in statins requires pH adjustment of the sample matrix to ensure that the target molecules are in their protonated form (pH should be 2 units below their pK

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsIonic LiquidsHumansLipidsPolyethylene GlycolsRosuvastatin CalciumHydroxymethylglutaryl-CoA Reductase InhibitorsIonic LiquidsLipidsPolyethylene GlycolsRosuvastatin CalciumCapsule phase microextractionDesigner sorbentsHPLCIonic liquidsStatinsUrine analysis

Identifiers

PMID37796344
PMCPMC10556171
OpenAlexW4387357608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.